Chitosan Wound Dressing Gel Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing wound dressing compositions made from chitosan gel lose their fluid retention ability and integrity within 24 hours due to degradation by enzymes in bodily fluids, leading to reduced effectiveness in managing exudate and potentially causing wound maceration.
Innovation Solution
A wound dressing composition comprising chitosan, chitosan salt, or chitosan derivative, combined with an anionic surfactant and a poloxamer, which forms a gel upon contact with bodily fluids and maintains integrity for at least 24 hours by cross-linking chitosan and inactivating lysozyme activity, preventing gel collapse.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If chitosan fibres are used to form a gel upon contact with bodily fluid, then fluid retention ability is improved, but gel integrity is lost within 24 hours due to enzyme degradation
Solution Approach 1:
The patent applies preliminary action by incorporating lysozyme-inactivating agents into the wound dressing composition before application. This pre-emptive measure neutralizes the enzymatic threat before it can degrade the gel structure, allowing the gel to maintain its integrity and fluid retention properties for an extended period beyond 24 hours.
Solution Approach 2:
The patent converts the harmful effect of lysozyme enzyme degradation into a beneficial outcome by using the enzyme's presence as a trigger for a protective response. The lysozyme-inactivating agents are specifically designed to react with lysozyme, transforming the harmful enzymatic degradation into a controlled interaction that preserves gel integrity while maintaining fluid retention capabilities.
2Reliability
If gel structure is maintained for extended period, then fluid retention is preserved, but degradation is delayed beyond desired healing time
Solution Approach 1:
The patent applies dynamics by creating a time-dependent, multi-stage degradation system. The gel maintains its structural integrity during the initial healing phase through enzyme inactivation, then progressively degrades as the protective agents are consumed or neutralized. This dynamic behavior allows the gel to be stable when needed and degrade when appropriate, matching the wound healing timeline.
Solution Approach 2:
The patent implements periodic action through a two-phase functionality: an initial protection phase where lysozyme-inactivating agents preserve gel integrity, followed by a degradation phase where the gel gradually breaks down. This periodic switching between stability and degradation allows the dressing to maintain reliability throughout the healing period while ensuring timely degradation for wound access and healing.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively retains fluid and maintains gel integrity for extended periods, reducing the need for frequent dressing changes and minimizing wound maceration, with the ability to degrade after healing, as demonstrated by maintaining fluid retention and conformability for up to 7 days or more.
Implementation Method 1
by cross-linking chitosan and inactivating lysozyme activity, preventing gel collapse
Implementation Method 2
by cross-linking chitosan and inactivating lysozyme activity, preventing gel collapse
Implementation Method 3
forms a gel upon contact with a fluid from a human or animal body
Implementation Method 4
The composition effectively retains fluid and maintains gel integrity for extended periods
Data Source
AI summary
The present invention relates to a wound dressing composition that is capable of gelling upon contact with a fluid derived from a human or animal body, and which is able to maintain the integrity of the gel for a period of time that is longer than about 24 hours.